Get the Stockscreener App
1.25
1.63%
0.02
Exicure Inc stock is traded at $1.25, with a volume of 16,544.
It is up +1.63% in the last 24 hours and down -18.83% over the past month.
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
See More
Previous Close:
$1.23
Open:
$1.23
24h Volume:
16,544
Relative Volume:
0.05
Market Cap:
$8.18M
Revenue:
$500.00K
Net Income/Loss:
$-9.78M
P/E Ratio:
-0.8107
EPS:
-1.5419
Net Cash Flow:
$-8.10M
1W Performance:
-3.10%
1M Performance:
-18.83%
6M Performance:
-64.99%
1Y Performance:
-75.00%
1-Day Range:
$1.22
$1.28
1-Week Range:
$1.22
$1.35
52-Week Range:
$1.05
$9.4799
Exicure Inc Stock (XCUR) Company Profile
Name
Exicure Inc
Sector
Industry
Phone
847-673-1707
Address
2430 N. HALSTED ST., CHICAGO, IL
Compare XCUR vs PSNYW, GOODO, SHMD, DWLD, QQQE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.625 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
5.00 | 394.14M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.92 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
3.15 | 315.90M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
47.39 | 0 | 0 | 0 | 0 | 0.00 |
QQQE
Direxion NASDAQ-100 Equal Weigh
|
120.75 | 0 | 0 | 0 | 0 | 0.00 |
Exicure Inc Stock (XCUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-21 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Dec-18-20 | Initiated | BMO Capital Markets | Outperform |
| Nov-20-19 | Initiated | Guggenheim | Buy |
Exicure Inc Stock (XCUR) Latest News
Exicure (XCUR) Price: Declines 11.54% to $1.15 in the Latest Reading; Range View: Support at $1.09 and Resistance at $1.21 Frame the Range for the Current SessionEqual Weight ETF - vinanet.vn
Exicure (XCUR) Quarterly Figures: EPS Comes in Below Forecast for This Review; Share Response: The Stock Ends Down 10.34% for the Current SessionGuidance Update - vinanet.vn
Exicure Stock Price Forecast. Should You Buy XCUR? - StockInvest.us
EXICURE, INC. Q2 2026: Revenue $0 Net income $(1.12M) — 10-Q Summary - TradingView
Exicure Deadline Alert - TMX Newsfile
Exicure Update - TMX Newsfile
Exicure Inc (XCUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Exicure Inc (XCUR) Stock News Today - TradingKey
XCUR|Exicure Inc|Price:1.345|Chg%:-0.010 - TradingKey
Trading Systems Reacting to (XCUR) Volatility - Stock Traders Daily
Exicure Shareholder Alert - TMX Newsfile
XCUR Looks 231.6% Overvalued on GF Value™ - GuruFocus
Exicure to issue shares to settle $1M clinical milestone payment - Investing.com
Exicure to issue shares to settle $1M clinical milestone payment By Investing.com - Investing.com Nigeria
Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance - The Manila Times
Exicure Announces Planned Issuance of Common Stock to Settle $1.0 Million Milestone Payment to GPCR Therapeutics - Quiver Quantitative
XCUR Q2 2022 Earnings: EPS Misses by 35.6% as No Revenue ReportedDividend Cut Risk - vinanet.vn
Exicure Inc. (XCUR) Rises 4.46% to $1.64 as Shares Approach Key Resistance LevelETF Creation Redemption - vinanet.vn
Exicure Inc (XCUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Exicure Inc (XCUR) Cash Flow - TradingKey
Exicure Inc (XCUR) Institutional Confidence - TradingKey
Exicure Inc (XCUR) Balance Sheet - TradingKey
Exicure Inc (XCUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Exicure Inc (XCUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Exicure Inc (XCUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
XCUR|Exicure Inc|Price:1.330|Chg%:-0.180 - TradingKey
XCUR|Exicure Inc|Price:1.760|Chg%:+0.050 - TradingKey
XCUR Q2 2022 Earnings: EPS Misses Estimates Amid Ongoing Operational ChallengesPost-Earnings Reaction - vinanet.vn
Exicure Inc (XCUR) Income Statement - TradingKey
Exicure, Inc. Revenue Breakdown – NASDAQ:XCUR - TradingView
Exicure Inc (XCUR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
XCUR stock trades on limited evidence as Exicure waits for filings - Ad-hoc-news.de
XCUR|Exicure Inc|Price:1.700|Chg%:-0.010 - TradingKey
Form 4 Exicure Inc For: 17 July By Investing.com - Investing.com Nigeria
Exicure Inc. (XCUR) Q2 2022 Earnings: EPS Misses Estimates Significantly, Stock Rises 3.7%Earnings Decline Risk - vinanet.vn
Form 13D/A EXICURE For: 17 July By Investing.com - Investing.com Nigeria
Exicure, Inc. (XCUR) holder Exicure HiTron regains 623,275 returned shares - Stock Titan
Exicure HiTron boosts Exicure (XCUR) holding to 2.22M shares, 34.87% - Stock Titan
XCUR Q2 2022 Earnings: Significant EPS Miss Highlights Ongoing Challenges for ExicureCost Structure Review - Vinanet
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Exicure (XCUR) Q2 2022 Earnings: Wider-Than-Expected Loss as Revenue Remains AbsentHigh Estimate Range - vinanet.vn
Trending Stocks Today | Exicure Shoots up 31.39% Post-Market - Moomoo
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Exicure Inc. (XCUR) Q2 2022 Earnings: Significant Earnings Miss and Negative Stock ReactionEarnings Sentiment Score - dars.gov.et
How Exicure Inc. (XCUR) Affects Rotational Strategy Timing - Stock Traders Daily
Stock Market News: Ethan Allen Interiors down by 90.10% while Exicure gains 99.48% during mid day trading - Business Upturn
Exicure Inc. (XCUR) Slips 7.89%: Key Support Levels Under ScrutinyDealer Delta - dars.gov.et
XCUR Q2 2022 Earnings: Wider-than-Expected Loss Drives Double-Digit DeclineFree Cash Flow Trends - dars.gov.et
Exicure stock holds its line. Company context stays front and center. - Ad-hoc-news.de
Debt to assets ratio of Exicure, Inc. – DUS:2H0 - TradingView
Non-controlling/minority interest of Exicure, Inc. – DUS:2H0 - TradingView
Exicure Inc Stock (XCUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Exicure Inc Stock (XCUR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Exicure HiTron Inc. | 10% Owner |
Jan 16 '26 |
Sale |
4.50 |
734,747 |
3,306,362 |
1,857,314 |
| Exicure HiTron Inc. | 10% Owner |
Jan 07 '26 |
Sale |
4.50 |
741,272 |
3,335,724 |
2,592,061 |
| SANGSANGIN INVESTMENT & SECURI | 10% Owner |
Dec 08 '25 |
Sale |
8.71 |
433,332 |
3,774,322 |
0 |
0.86%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):